MedTrace Logo

A Short CONSORT Checklist for Peer Reviewers to Improve the Reporting of Randomised Controlled Trials Published

NCT05820971 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 243

Last updated 2023-04-24

No results posted yet for this study

Summary

Transparent and accurate reporting is key, so that readers can adequately interpreting the results of a study. Despite improvement with implementation of the CONSORT Statement (CONsolidated Standards for Reporting Trials), there remain major reporting deficiencies in published randomized controlled trials (RCT). The aim of this project is to evaluate whether reminding peer reviewers of the most important CONSORT items (including a short explanation of those items) will result in higher adherence to CONSORT guidelines in published RCTs. During the standard peer-review process, peer-reviewers will be randomly allocated to use either (i) a short version of the CONSORT checklist including the ten most important and poorly reported CONSORT items as defined by a group of experts of the CONSORT Statement (C-short); or (ii) no checklist. The aim is to find an intervention which improves the reporting, making it easier for readers to adequately interpret the presented results.

Conditions

  • Adequate Reporting in Randomized Controlled Trials

Interventions

OTHER

C-short plus usual practice

Peer reviewer will be reminded of the following 10 CONSORT items (including a short description): * Outcomes (6a) * Sample size (7a) * Sequence generation (8a) * Allocation concealment (9) * Blinding (11a) * Outcomes and estimation (17a/b) * Harms (19) * Registration (23) * Protocol (24) * Funding (25)

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Sally Hopewell, Ass. Prof · Centre for Statistics in Medicine, Oxford University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-15
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820971 on ClinicalTrials.gov